Literature DB >> 13761605

Comparison of dissolution and absorption rates of different commercial aspirin tablets.

G LEVY.   

Abstract

Entities:  

Keywords:  ACETYLSALICYLIC ACID

Mesh:

Substances:

Year:  1961        PMID: 13761605     DOI: 10.1002/jps.2600500503

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  19 in total

Review 1.  Simple analgesics.

Authors:  J Parkhouse
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  An in situ dissolution study of aspirin crystal planes (100) and (001) by atomic force microscopy.

Authors:  A Danesh; S D Connell; M C Davies; C J Roberts; S J Tendler; P M Williams; M J Wilkins
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

3.  Perspectives on the history and scientific contributions of Gerhard Levy.

Authors:  Ho-Leung Fung; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-24       Impact factor: 2.745

4.  Inhibition of platelet release reaction by acetylsalicylic acid.

Authors:  R M Rowan; G A McDonald; R L Renton; S J Corne; D F Brown
Journal:  Postgrad Med J       Date:  1976-02       Impact factor: 2.401

Review 5.  Bioavailability and bioequivalence: focus on physiological factors and variability.

Authors:  Vangelis Karalis; Panos Macheras; Achiel Van Peer; Vinod P Shah
Journal:  Pharm Res       Date:  2008-06-13       Impact factor: 4.200

6.  Levy G, Hayes B, "Physiochemical basis of the buffered acetylsalicylic acid controversy. New Engl. J. Med. 262:1053-1058 (1960)"--the backstory.

Authors:  Gerhard Levy
Journal:  AAPS J       Date:  2011-05-11       Impact factor: 4.009

Review 7.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

8.  An overview about biopharmaceutics in Europe.

Authors:  Jean-Marc Aiache
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

9.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 10.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.